---
figid: PMC5500446__nihms843111f2
figlink: /pmc/articles/PMC5500446/figure/F2/
number: F2
caption: Catecholamine (CA) mediated activation of β2-adrenergic receptor (β2AR) lead
  to Akt and endothelial nitric oxide synthase (eNOS) activation. eNOS converts the
  amino acid L-arginine to form L-citrulline and the free radical NO. The NO then
  reacts with glutathione (GSH) to form S-nitrosoglutathione (GSNO). GSNO transfers
  its NO group to the sulfhydryl (-SH) group of the Cysteine in position 340 of GRK2
  protein to form S-nitrosothiol-GRK2 (SNO-GRK2). Following this modification GRK2
  loses its ability to phosphorylate and desensitize/downregulate the β2AR leading
  to an enhancement of its signaling pathway.
pmcid: PMC5500446
papertitle: 'GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular
  disease.'
reftext: Alessandro Cannavo, et al. Cell Signal. ;41:33-40.
pmc_ranked_result_index: '38539'
pathway_score: 0.9601327
filename: nihms843111f2.jpg
figtitle: 'GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular
  disease'
year: ''
organisms:
- Cricetulus griseus
- Mus musculus
- Rattus norvegicus
- Adeno-associated virus
- Homo sapiens
- Canis lupus familiaris
- Bos taurus
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5500446__nihms843111f2.html
  '@type': Dataset
  description: Catecholamine (CA) mediated activation of β2-adrenergic receptor (β2AR)
    lead to Akt and endothelial nitric oxide synthase (eNOS) activation. eNOS converts
    the amino acid L-arginine to form L-citrulline and the free radical NO. The NO
    then reacts with glutathione (GSH) to form S-nitrosoglutathione (GSNO). GSNO transfers
    its NO group to the sulfhydryl (-SH) group of the Cysteine in position 340 of
    GRK2 protein to form S-nitrosothiol-GRK2 (SNO-GRK2). Following this modification
    GRK2 loses its ability to phosphorylate and desensitize/downregulate the β2AR
    leading to an enhancement of its signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - GRK2
  - AKT3
  - NOS3
  - ADRB2
  - Cys
  - L-Arginine
  - GSH
  - GSNO
  - SNO
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: GRK2
  symbol: GRK2
  source: hgnc_symbol
  hgnc_symbol: GRK2
  entrez: '156'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: B2AR
  symbol: B2AR
  source: hgnc_alias_symbol
  hgnc_symbol: ADRB2
  entrez: '154'
chemicals:
- word: Cys
  source: MESH
  identifier: C046557
- word: L-Arginine
  source: ''
  identifier: ''
- word: GSH
  source: MESH
  identifier: D005978
- word: GSNO
  source: ''
  identifier: ''
- word: SNO
  source: MESH
  identifier: C474014
diseases: []
figid_alias: PMC5500446__F2
redirect_from: /figures/PMC5500446__F2
figtype: Figure
---
